Cargando…
Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system
Despite explosive growth in the development of nano-drug delivery systems (NDDS) targeting tumors in the last few decades, clinical translation rates are low owing to the lack of efficient models for evaluating and predicting responses. Microfluidics-based tumor-on-a-chip (TOC) systems provide a pro...
Autores principales: | Tian, Chutong, Zheng, Shunzhe, Liu, Xinying, Kamei, Ken-ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301849/ https://www.ncbi.nlm.nih.gov/pubmed/35858898 http://dx.doi.org/10.1186/s12951-022-01552-0 |
Ejemplares similares
-
Recent advances in anti-multidrug resistance for nano-drug delivery system
por: Wang, Changduo, et al.
Publicado: (2022) -
The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems
por: Yang, Canyu, et al.
Publicado: (2021) -
Recent Advances in Antimicrobial Nano-Drug Delivery Systems
por: Zong, Tong-Xin, et al.
Publicado: (2022) -
Advanced Nano-Carriers for Anti-Tumor Drug Loading
por: Xiang, Jia, et al.
Publicado: (2021) -
Recent advances in nano-drug delivery systems for synergistic antitumor immunotherapy
por: Zhao, Bonan, et al.
Publicado: (2022)